Asset Intelligence / Hyperliquid Context
RKLB
Archive-backed market intelligence for RKLB: every HIPERWIRE mover article tied to this asset, plus a client-refreshed live market panel.
RKLB references 1 share of Rocket Lab Corporation common stock (Nasdaq: RKLB), quoted in USD. Rocket Lab provides launch services, spacecraft, satellite components, and related systems.
Live Structure
Market Status
Loading current market structure…
- Builderxyz
- Categorystock
- Tracked Marketxyz:RKLB
- Latest TweetOpen
No other live markets from this builder in the current screener.
No same-category alternatives are live in the current screener snapshot.
Archive Summary
Latest Archived Thesis
RKLB Rebounds as the Space Force Triples the Lane 1 Launch Pot Neutron Sits In
Rocket Lab's Hyperliquid perp is up 11.20% to $73.29, and this bounce has a real, same-day catalyst behind it. On July 21 the U.S. Space Force tripled the NSSL Phase 3 Lane 1 contract ceiling to $17 billion — the on-ramp pool Rocket Lab's Neutron is part of — pushing the total launch program ceiling to roughly $30 billion. The move landed on a name that was down about 55% from its May high and deeply oversold after Piper Sandler's July 16 neutral rating. Bigger federal launch dollars are a genuine tailwind, but they don't convert to revenue until Neutron flies, and the $8 billion Iridium deal still hangs over the story.
Archive
All RKLB Mover Articles
RKLB Rebounds as the Space Force Triples the Lane 1 Launch Pot Neutron Sits In
Rocket Lab's Hyperliquid perp is up 11.20% to $73.29, and this bounce has a real, same-day catalyst behind it. On July 21 the U.S. Space Force tripled the NSSL Phase 3 Lane 1 contract ceiling to $17 billion — the on-ramp pool Rocket Lab's Neutron is part of — pushing the total launch program ceiling to roughly $30 billion. The move landed on a name that was down about 55% from its May high and deeply oversold after Piper Sandler's July 16 neutral rating. Bigger federal launch dollars are a genuine tailwind, but they don't convert to revenue until Neutron flies, and the $8 billion Iridium deal still hangs over the story.
RKLB Gives Back Its Run as the Highest-Beta Space Names De-Risk
Rocket Lab's Hyperliquid perp is down about 10% to $91.53, but there's no company-specific bad news behind it. RKLB fell roughly 7% on July 6 alongside AST SpaceMobile, Intuitive Machines and the freshly public SpaceX — a sector-wide de-risking after a torrid run. The stock had climbed about 25% in the week ending July 2, and traders are still reassessing the $8 billion Iridium acquisition and the $3.6 billion of bridge financing behind it. This is profit-taking in the market's twitchiest space names, not a crack in the fundamentals.
RKLB Bounces Off June Lows on a NASA Award and a Perfect 10th Synspective Launch
Rocket Lab's Hyperliquid perp is up about 13% to $95.75, recovering from a brutal June that had dragged the stock roughly 37% below its May record. The bounce rides two operational wins in 48 hours: NASA awarded three new Electron launches on June 25, and two days later Rocket Lab nailed its 10th straight Synspective mission at 100% success. This is a recovery off oversold levels in a name whose backlog never cracked even as the tape did. Neutron's Q4 debut is still the trade that actually matters.
RKLB Gives Back Its SpaceX Bounce as SPCX Finally Trades
Rocket Lab's Hyperliquid perp ran to a $122.98 high early Friday and then sold off to a $103.27 low, down about 17% over 12 hours, as SpaceX began trading under SPCX in the largest IPO ever. This is a textbook sell-the-news rotation: the proxy premium that built up in listed space names while SpaceX was private leaked out the moment the real thing became investable. Virgin Galactic fell 24% and AST SpaceMobile 10% in the same shakeout. The cruel part of the timing is that RKLB's own CFO had spent the prior session selling the SpaceX IPO as a Neutron tailwind, and the stock bounced 13% on it; that reframe lasted exactly until SPCX opened.
RKLB Rebounds as Its CFO Flips the SpaceX IPO From Threat Into a Neutron Tailwind
RKLB is up 13.30% over 21 hours to about $115.70, a hard bounce off Wednesday's $105.05 close and a near-total reversal of last week's halo-trade unwind. The catalyst is RKLB's own CFO: at a June 10 conference, Adam Spice argued that SpaceX's drift toward Starlink, Starship and data centers leaves Neutron a 'very nice spot' in commercial launch — recasting the SpaceX IPO from a draining event into a tailwind. The bounce lands right as the classified HASTE Curveball hypersonic test flies from Wallops and one day before SpaceX debuts under SPCX, the same listing that pulled RKLB lower a week ago.
RKLB Gives Back Its SpaceX Halo Pop as IPO Terms Land and the Bear Trade Organizes
RKLB is down 10.57% over 24 hours to about $109.50, a sharp reversal after weeks of riding the SpaceX IPO roadshow higher. The catalyst that lifted the entire public space complex has flipped: SpaceX's IPO terms are now public at a $135 share price and a $1.77 trillion valuation, Morningstar pegs fair value at less than half that, and hedge funds are lining up shorts through the one bank left out of the underwriting syndicate. The same June 12 debut that gave RKLB its proxy bid is now the event that drains it.
RKLB Catches the SpaceX IPO Halo Trade as Analyst Targets Stack to $132
RKLB is up 9.64% over 24 hours to about $122.90, a second straight green day as SpaceX's IPO roadshow drags the entire public space complex higher into a June 12 debut. The move stacks on top of a wave of analyst target raises — Clear Street to $129, Stifel to a street-high $132 — behind a record $2.2 billion backlog. But this is a sector halo trade, not a fresh Rocket Lab catalyst, and the IPO that is lifting the name now is the same event that finally gives it a public comp.
RKLB Pulls Back 9% From Its $130 ATH As the 69% Week Cools Off
After a five-session, 69% run that stacked the May 7 Q1 beat, the Cowen-to-$120 upgrade wave, the Mynaric AG close, and a clean Neutron stage separation test into a single repricing, RKLB ran out of new news. Cash RKLB tagged a fresh $130.37 intraday all-time high before fading back into the low-$123s, and the xyz:RKLB perp followed it down for a 9.04% 24h move. At roughly 108x trailing sales versus a 14.6 five-year average, on no specific bad headline, this prints as profit-taking rather than a thesis change.
RKLB Adds 19.83% as Neutron Separation Test Clears and Cowen Tags $120 PT
Rocket Lab cleared a full-flight-load Neutron stage separation test campaign over the weekend, and the analyst desks walked into Monday raising price targets across the board. Cowen took the street-high to $120, Cantor moved to $96, Stifel to $110 — all stacked on top of the May 7 Q1 print that delivered $200.3M in revenue and a $2.2B backlog up 108% year over year. The xyz:RKLB perp is following spot into the gap-up zone, marking $123.80 after cash RKLB traded a $102.99 to $122.93 intraday range on roughly 40M shares versus a 24M average.
RKLB Lands Golden Dome SBI Role and $30M Anduril HASTE Block
Rocket Lab dropped Q1 numbers on May 7 and surfaced two defense wires on the same day: selection with Raytheon for the U.S. Space Force's Space Based Interceptor program — the kinetic backbone of Golden Dome — and a $30M Anduril contract for three HASTE hypersonic test launches. The market read both as a structural re-rate, not a one-quarter beat. The xyz:RKLB perp continued past the post-earnings tape and now prints $102.40, a clear premium to where cash RKLB closed at $78.58 the prior session.
RKLB Outruns Its Implied Move on $200M Q1 and 108% Backlog Jump
Rocket Lab's Q1 print cleared every line of guidance, with $200.3M in revenue, a 38.2% GAAP gross margin, and a backlog that jumped 108% year over year to $2.2 billion. The 24/7 HIP-3 perp ran the move ahead of the cash open and ended up outpacing the 13.88% post-earnings swing options had been pricing in. Underneath the beat: a closed Mynaric deal, a fresh definitive agreement to acquire Motiv Space Systems, and a Q2 revenue guide of $225-240M that flags margin compression as Neutron spend ramps.
How to Trade RKLB (Rocket Lab) on Hyperliquid
RKLB is a HIP-3 perpetual futures contract that tracks one share of Rocket Lab Corporation common stock, the end-to-end space company behind the Electron small-lift rocket and the upcoming Neutron medium-lift vehicle. The market lets onchain traders express views on a $1.85 billion backlog, a fast-growing defense pipeline, and a high-stakes Neutron debut slipping into late 2026. This guide breaks down what the asset is, why it matters, and what to watch when trading the contract.
Background reading selected from this asset's symbol, builder context, and archived catalyst coverage.